Author

J. Fujita

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Ramalho· 1 shared A. Marques-Ramos· 1 shared A. Umemura· 1 shared B. Pereira· 1 shared H. Akiba· 1 shared H. Higashitsuji· 1 shared H. Kamada· 1 shared H. Ohno· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Ramalho

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Internal Translation of p53 Oncoproteins During Integrated Stress Response Confers Survival Advantage on Cancer Cells

M. J. Lopez-Iniesta, R. Lacerda, A. C. Ramalho, S. N. Parkar, A. Marques-Ramos, B. Pereira, L. Miyawaki, J. Fujita, R. Hrstka, L. Romao, M. M. Candeias

This study identifies the integrated stress response (ISR) as a trigger for p53 oncoprotein variants, showing their role in cancer cell survival and proposing a therapeutic strategy.

bioRxiv · Mar 3, 2023 · PreprintCancer Biology

Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection

H. Akiba, J. Fujita, T. Ise, K. Nishiyama, T. Miyata, T. Kato, K. Namba, H. Ohno, H. Kamada, S. Nagata, K. Tsumoto

This study develops a biparatopic anti-TNFR2 antagonist that binds in a 1:1 ratio, preventing unwanted signal transduction and suppressing regulatory T cell proliferation.

bioRxiv · Dec 15, 2022Biochemistry

Onecut1 partially contributes to liver progenitor cell transition and acquisition of metastatic potential in hepatocellular carcinoma.

Y. Liu, H. Higashitsuji, K. Itoh, K. Yamaguchi, A. Umemura, Y. Itoh, J. Fujita

bioRxiv · Sep 20, 2022 · PreprintCancer Biology